Active — Not RecruitingNot Applicable

Psychoeducation for Uveal Melanoma

United States108 participantsStarted 2023-11-07

Plain-language summary

This clinical trial evaluates a video-based psychoeducational intervention for patients with uveal melanoma. Uveal melanoma (UM) is a rare intraocular cancer. UM patients face an uncertain course of survivorship in terms of their visual acuity, treatment-related side effects, and risk for eventual metastasis of the cancer. Learning about patients' thoughts and reactions to informational resources may better support patients during ocular melanoma survivorship.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adults (age 18 years and older at visit 1) * History of uveal melanoma as documented in their University of California, Los Angeles (UCLA) medical record * Receipt of uveal melanoma treatment and/or ongoing follow-up care at the UCLA Jules Stein Eye Institute, as documented in their UCLA medical record * Ability to read, write, and converse in English * Access to the internet via a computer or cell phone * Access to a personal email address * Written informed consent obtained from subject or subject's legal representative and ability for subject to comply with the requirements of the study Exclusion Criteria: \-

What they're measuring

Change in illness perceptions of disease control

Timeframe: From baseline to day 77

Change in illness perceptions of chronicity

Timeframe: From baseline to day 77

Change in illness perceptions of coherence

Timeframe: From baseline to day 77

Trial details

NCT IDNCT06075589

SponsorJonsson Comprehensive Cancer Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-08-14

View on ClinicalTrials.gov More Uveal Melanoma trials